Chapters: 00:00 Intro & Jay Campbell Joins 03:33 Peptide Sciences Shutdown Explained 08:10 Big Pharma Pressure & Market Control 14:34 GLP-1 Monopoly, FDA & Market Shift 18:39 Fake Peptides & Bad Actors 23:20 New Regulations & Testing Standards 27:21 Compounding Pharmacies Under Attack 33:33 MedV, AI Doctors & Affiliate Risk 39:33 Whats Coming Next in Peptides 45:22 FLGR-242 & Clotho Breakdown 55:35 Nootropics & Cognitive Peptides 58:13 If He Could Only Take One Peptide 1:19:18 Live Event Plans & Final Plug We cover: GLP-1 Basics (Semaglutide & Tirzepatide) Designed for blood sugar regulation + appetite control Slows gastric emptying keeps you fuller longer Improves insulin sensitivity Best for: Fat loss Appetite control Metabolic health The Problem With Most Users 95% of people misuse GLPs No focus on protein intake No resistance training No hormone optimization Result: Muscle loss Slowed metabolism Poor long-term results Reality Check GLPs are NOT magic Without proper nutrition + training you get skinny fat Education is the missing piece for most users Retatrutide (Next-Level GLP) Triple agonist (GLP-1, GIP, Glucagon) Significantly stronger than semaglutide Increases fat loss AND metabolic output Potential to outperform all current fat loss drugs Future direction of the industry Whats Coming Next (Pipeline) Stage 4: Adds myostatin inhibition (muscle growth potential) Stage 5: Increases metabolic rate even at rest Future compounds may combine: Fat loss Muscle growth Metabolic enhancement Real Performance Insight GLPs should be paired with: High protein diet Strength training Proper recovery Microdosing can reduce side effects and improve sustainability Industry Truth Big pharma controls the GLP space Pricing and access will continue to be a major issue Research space is evolving rapidly Quality control and education will separate real results from scams Follow us on social media: JD's Instagram: Will's Instagram: Warrior-Makers Community: Jay Campbells Website: Jays Instagram: Jays X (Twitter): Peptide Q&A #36 Hair Transplants, Mitochondrial Protocols, Female Fat Loss, TRT Support, Peptide Dosing & Alcohol on RETA Medical Disclaimer: We are not doctors
It is NOT approved for heart failure, mitochondrial myopathy, neurodegeneration, eye disease, anti-aging, fat loss or athletic performance
For the medication to be effective, doctors will adjust a persons dose over time, and they may have to continue taking it even while in remission
Supplementation with Cu-containing adjuvants in patients diagnosed with Cu or Se deficiency may positively affect disease regression (Sobczyk and Gaunt, 2022)
Sulphur is sticky and grabs ahold of free radicals, toxins, and dangerous heavy metals, allowing your body to excrete these harmful substances
